Assertio to Participate in AGP Healthcare Conference on May 21
Assertio Holdings (Nasdaq: ASRT), a pharmaceutical company, announced that its Chief Financial Officer, Ajay Patel, will present at the Alliance Global Partners Virtual Healthcare Company Showcase on May 21, 2024, at 3:40 p.m. Eastern Time. The presentation will provide an overview of Assertio's business and will be accessible through AGP's healthcare equity research team. Interested investors can join by contacting their AGP representative or Assertio investor relations. Further details will be available on the day of the event at https://investor.assertiotx.com.
- Assertio's participation in the AGP Healthcare Conference increases visibility and investor engagement.
- Ajay Patel's presentation will offer a comprehensive overview of the company's business, potentially attracting new investors.
- The event provides a platform for networking and showcasing Assertio's differentiated pharmaceutical products.
- There is no new financial or clinical data disclosed in the announcement, limiting immediate impact on stock valuation.
- The dependency on a virtual platform might reduce the effectiveness of engagement compared to in-person events.
LAKE FOREST, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the Alliance Global Partners Virtual Healthcare Company Showcase to be held virtually on May 21, 2024. Mr. Patel will present an overview of Assertio’s business at 3:40 p.m. Eastern Time.
The event is hosted by AGP’s healthcare equity research team. Investors interested in joining the conference can request to do so via their AGP representative, or contact Assertio investor relations via mkreps@darrowir.com.
Presentation information will be available on the day of the event and can accessed at https://investor.assertiotx.com.
About Assertio
Assertio is a commercial pharmaceutical company offering differentiated products to patients. We have built our commercial portfolio through acquisition or licensing of approved products. Our comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting, and trade and distribution. To learn more about Assertio, visit www.assertiotx.com.
Forward Looking Statements
Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio, including risks related to our ability to realize the benefits from our operating model, successfully integrate new assets, explore new business development initiatives, and successfully recruit a successor CEO on a timely basis. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” “believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,” “objective,” “opportunity,” “outlook,” “plan,” “position,” “potential,” “predict,” “project,” “prospective,” “pursue,” “seek,” “should,” “strategy,” “target,” “would,” “will,” “aim” or other similar expressions that convey the uncertainty of future events or outcomes and are used to identify forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the control of Assertio, including the risks described in Assertio’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”) and in other filings Assertio makes with the SEC from time to time. Investors and potential investors are urged not to place undue reliance on forward-looking statements in this communication, which speak only as of this date. While Assertio may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to update or revise any forward-looking-statements contained in this press release whether as a result of new information or future events, except as may be required by applicable law.
Investor Contact
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
FAQ
When and where is Assertio presenting at the AGP Healthcare Conference?
What will be discussed in Assertio's presentation at the AGP Healthcare Conference?
How can investors join Assertio's presentation at the AGP Healthcare Conference?
Where can details of Assertio's AGP Healthcare Conference presentation be accessed?
